[Brief Introduction of Seminar]

Extracellular vesicle isolation is fundamental technology for research and therapeutic industries, where method selection determines commercial viability.

These handy, accurate tools streamline therapeutic research workflows, from process QC to final product development. By ensuring high-yield, pure preparations essential for regulatory approval, we are opening pathways for next-generation therapeutics across veterinary and human medicine. 

[Brief Introduction of Speaker]​

Dr. Kyusang Lee serves as CEO of ExoDiscovery Technologies Inc. and LabSpinner Inc., leading revolutionary extracellular vesicle-based liquid biopsy platforms for cancer monitoring. He holds a Ph.D. in Materials Science and Engineering from the University of Illinois at Urbana-Champaign. With over 25 years of biotechnology leadership, Dr. Lee co-founded and served as CTO of Clinomics Inc., achieving successful IPO in 2020. He previously led biochip development at Samsung Electronics for 16 years and founded LabSpinner Inc. Dr. Lee received Korea's 2019 National Top 100 R&D Performances award and has secured funding for 15+ major government projects, establishing him as a distinguished serial entrepreneur in molecular diagnostics.​

[Brief Introduction of Seminar]

Exosomes are bioactive vesicles gaining attention for their proven benefits in anti-inflammation, regeneration, and skin barrier restoration. Their applications are rapidly expanding in the aesthetics and regenerative medicine industries. However, for the successful growth of the exosome industry, challenges such as GMP-grade manufacturing, quality control, and facility compliance must be addressed. This presentation highlights the importance of producing safe and effective exosome-based products through standardized processes and validated testing. We will also introduce current therapeutic development trends and present various clinical case studies demonstrating the potential of exosomes across medical and aesthetic fields.

[Brief Introduction of Speaker]​

Byong Cho is a pioneer in the exosome industry and has served as founder, CEO, and CTO of ExoCoBio Inc. since 2017. With a background in molecular biology (BS, MSc) and a Techno-MBA from KAIST, he has over two decades of success in biotech management and venture capital, including the IPOs of Medytox and Viromed, now valued at a combined $5 billion.

​

[Brief Introduction of Seminar] ​As the global population continues to age, there is a growing interest worldwide in foods and functional ingredients that support healthy aging. This seminar will take an in-depth look at the role of probiotics in the field of Healthy Aging, focusing on key ingredients developed by Lallemand Health Solutions, a global leader in the probiotics industry.

[Brief Introduction of Speaker]​

Senior Sales Manager at Lallemand Health Solutions, overseeing sales in the Asia-Pacific (APAC) region, excluding Greater China.​​

[Brief Introduction of Seminar] Join us for a look at Lonza’s Advanced Synthesis Platform, supporting seamless progression from early development to commercial supply. We’ll highlight our expertise in HPAPI development and manufacturing, along with integrated early-phase services including our AI-enabled route scouting and high-throughput experimentation. We’ll conclude with an overview of our growing bioconjugate offering, enabling end-to-end support for complex therapies. Don’t miss this opportunity to discover how Lonza can accelerate your molecules to the market.

[Brief Introduction of Speaker]​​

Junghae Yun holds a B.S. in Environmental Systems from UC San Diego. She began her career at Samsung Biologics as a Sales Account Manager, supporting global clients and CDMO business development. At SK bioscience, she led strategic initiatives for CGT CDMO expansion. She is currently a Senior Business Development Manager for the APAC region at Lonza Advanced Synthesis, focusing on small molecule CDMO growth.​​

[Brief Introduction of Seminar​]

What are the main challenges for Korean companies entering the EU market and how can Innate help its partners penetrate the market.​​

[Brief Introduction of Speaker​]

Eng. Carotenuto is responsible for the commercial side of Innate's CMO/CDMO production, creating synergies between the company and its customers for both existing and new projects.​​ 

[Brief Introduction of Seminar] ​Investigation of the Preventive Effects of Amaranth Extract on Muscle atrophy

[Brief Introduction of Speaker]​

Mihyang Kim is a research scientist at the National Institute of Crop Science, Rural Development Administration (RDA), where she conducts research on the physiological activities of bioactive compounds derived from food crops for their functional applications.​​

[Brief Introduction of Seminar] Functional Properties of Extract and Fermented Material from the Native Medicinal Plant Peucedanum japonicum

[Brief Introduction of Speaker]​​

​He holds a degree in Oriental Pharmacy and is currently developing food and pharmaceutical materials at the Industrial Crop Utilization Division, National Institute of Horticultural and Herbal Science.​

[Brief Introduction of Seminar]

​Composition for promoting growth of probiotics containing polysaccharide extracted from edible insects as an effective ingredient.

Conducting functional research on insect bioactive substances using various insects for food and medicine in the Insect Materials Research Lab of the Industrial Insects Division of the Agricultural Biology Department of the National Institute of Agricultural Sciences ​

[Brief Introduction of Seminar]​

The effect of inhibiting osteoclast differentiation was confirmed using the Protebia brevitaris slensis extract, and based on this, osteoporosis relief was confirmed by treating osteoporosis-induced mice.

[Brief Introduction of Speaker]​

​The Industrial Insect Division of the National Institute of Agricultural Sciences is conducting functional studies using various edible insects.​